Given the functional resemblance between PALI1 to JARID2 and their potential role as tumour suppressors in hematopoietic malignancies, we wished to determine if PALI1 has a negative effect on the proliferation of myelogenous leukaemia cells. Here, JARID2 is linked to neoplasm.